Efficiency of high-intensity therapy with rosuvastatin for secondary prevention of cardiovascular complications in patients with a very high risk - Kolmakova, T. E.; Alekseeva, I. A.; Tmoyan, N. A.; Ezhov, M. V. (Aterotromboz (Online), 2022)
Keywords: covid-19; dyslipidemia; extreme cardiovascular risk; low-density lipoprotein cholesterol (ldl-c); rosuvastatin; very high cardiovascular risk